Anxiety, Mood, and the Change No One Warned You About
Body · The Reading Room, Vol. 74 · 6 min read · What the GABA-allopregnanolone mechanism actually explains, and the 3-day check that gives the anxiety a shape
Based on the published research of C. Neill Epperson, MD — Robert Freedman Endowed Professor and Chair of Psychiatry, University of Colorado Anschutz Medical Campus, whose work examines how reproductive hormone transitions act on mood and anxiety. Faculty profile
New menopause anxiety isn’t a personality change. It’s hormones hitting the brain’s calming system directly. What’s happening, plus a 3-day pattern check.
Red light, empty intersection, nothing happening. And your chest goes tight, heart going fast, hands gripping the wheel like the car in front of you is about to do something. It isn’t. Nobody’s there. You sit with it until the light changes, drive the rest of the way normal, and spend the evening turning over a question you’ve never had to ask before: since when am I an anxious person.
You’re not, particularly, or you weren’t. That distinction matters more than it sounds like it should, and it’s the kind of thing you’d never bring up at work, since the whole point of the last twenty years was being the one who doesn’t rattle.
The short answer: new or sharply worse menopause anxiety is usually hormonal, not a personality change, driven by estrogen and progesterone swinging unpredictably and landing directly on the brain’s chemical calming system, and for a large share of women it shows up as one of the very first signs of the transition, before any hot flash does.¹²
The skim version
- More than 70 percent of women report substantial mood and emotional changes across perimenopause and menopause. This is common, not rare.³
- Estrogen doesn’t just decline. It surges and crashes erratically in perimenopause, and clinicians report the crashes are what tend to trigger anxiety spikes.¹
- Progesterone drops earlier and more sharply than estrogen, converting to less allopregnanolone, the brain’s own calming neurosteroid — weakening the GABA system directly.²
- For many women, new anxiety and brain fog arrive before hot flashes or period changes, which is exactly why it gets missed or misread.¹
- A short 3-day pattern check turns a vague, frightening feeling into a specific, trackable one.
In this article: Why anxiety can appear out of nowhere · Is this really new, or was it always there · When it’s worth a longer conversation · The 3-day pattern check · FAQ
Why does menopause anxiety show up out of nowhere, with no clear trigger?
Because the hormone shift itself isn’t a smooth slope. Physician and author Mary Claire Haver, MD, describes perimenopause in her clinical practice as a “zone of chaos”: estrogen doesn’t quietly decline, it surges and crashes, sometimes within the same week, as the brain sends louder and louder signals trying to get the ovaries to respond.¹ Each crash lands directly on brain chemistry, specifically the systems that regulate serotonin, dopamine, and the brain’s main calming neurotransmitter, GABA.
Progesterone adds a second layer, and its decline usually starts earlier and runs steeper than estrogen’s. Progesterone converts in the brain to a neurosteroid called allopregnanolone, which directly boosts GABA-A receptor activity, the same calming system targeted by anti-anxiety medications. Research on allopregnanolone’s role in reproductive mood disorders has found that when this conversion falters, the result is a weaker brake on the nervous system, precisely when the estrogen swings are hitting hardest.² Two systems destabilizing at once, not one.
What the research found
Schiller, Schmidt and Rubinow’s review of allopregnanolone’s role in reproductive mood disorders lays out the mechanism directly: as progesterone falls, so does its conversion to allopregnanolone, and allopregnanolone is one of the brain’s most potent natural GABA-A receptor activators — the same receptor anti-anxiety medications target. Less of it means a measurably weaker calming system, not a metaphor for one.²
The limitation: this is a mechanistic review, not a trial that tracked anxiety symptoms hour by hour in perimenopausal women specifically. It explains why the chemistry could produce sudden spikes; it doesn’t measure how often, or how severely, in an average woman’s week. NAMS-backed clinical guidelines, cited below, are where the population-level prevalence data actually comes from.²³
Put plainly: the gas pedal is getting pressed harder and less erratically by estrogen’s swings, while the brake, the GABA system progesterone normally supports, is simultaneously wearing thin. Either shift alone would be noticeable. Together, in the same stretch of years, they explain why anxiety at this age can feel disproportionate to whatever small thing supposedly triggered it. The trigger was never really the point.
The trigger was never really the point.
This is also, in Haver’s clinical experience, often the very first sign of the transition, arriving before the hot flashes, the missed periods, or any of the symptoms women are actually told to expect. New anxiety in your late thirties or forties can look, from the inside, like nothing hormonal at all. It looks like something is wrong with you specifically, which is precisely the misread this mechanism sets up.¹
That misread costs time. Most of the public conversation about menopause still centers on hot flashes and periods, so a woman whose first and loudest symptom is a racing heart at a red light has no obvious reason to connect the two. She goes looking for what’s wrong with her mind, her marriage, her job, her nerves, when the actual first domino was a hormone panel nobody thought to run yet because nothing “menopausal” has happened on the outside.
Is this genuinely new anxiety, or was some version of it always there and just easier to manage?
Both patterns are real, and telling them apart matters less than it might seem, because the mechanism check is the same either way. If anxiety is a completely new experience, the hormonal swing is very likely the primary driver. If you’ve always run a bit anxious and it’s noticeably sharper now, less able to soothe itself, staying activated longer after the trigger passes, that’s consistent with the same weakened GABA system giving less support to a pattern that used to self-regulate more easily.
Either way, the useful reframe is the same: this is chemistry meeting a bad week, not evidence of a personality collapsing. If the anxiety is riding in with a foggier brain too, word-finding trouble, feeling one step behind in meetings, that’s frequently the same hormonal weather doing double duty. The brain fog question worth asking before you assume the worst covers that overlapping half of it.
| Hormonal anxiety pattern | Worth a longer clinical conversation | |
|---|---|---|
| Onset | New or noticeably sharper in your late 30s to 50s | Present at any age, unrelated to a hormonal timeline |
| Pattern | Comes in waves, often tracks with sleep and cycle changes | Constant, or steadily worsening regardless of pattern |
| Physical company | Often alongside hot flashes, brain fog, sleep disruption | Panic attacks, physical symptoms needing urgent evaluation |
| Function | Uncomfortable but you’re still functioning day to day | Significantly interfering with daily functioning |
Definition: menopause anxiety is new or intensified anxiety driven by fluctuating estrogen and declining progesterone acting on the brain’s mood and calming systems, distinct from a separately occurring anxiety disorder.²
If the anxiety arrived on top of a load you were already carrying alone, the Quiet Audit is ten minutes on the load. Start here.
When does new anxiety at this age deserve more than a wait-and-see approach?
Bring it to a clinician sooner rather than later if it includes panic attacks, if it’s steadily worsening rather than coming in waves, or if it’s meaningfully interfering with work or relationships rather than sitting alongside them as an uncomfortable but manageable layer. Informational, not medical advice; see your clinician for a personal evaluation. NAMS-backed clinical guidelines recognize mood symptoms as a legitimate, treatable part of the menopause transition, not something to simply outlast.³
None of this requires you to solve which came first, the hormones or the stress of a stretched-thin life. Both are usually true at once, and both are worth naming to whoever you bring this to.
It’s worth saying plainly that bringing this up doesn’t require having it all figured out first. “I’ve never had anxiety like this before, and it started around the time my cycle got unpredictable” is a complete, useful sentence to open with. A good clinician will take that seriously without you needing to arrive with a diagnosis already attached to it.
The source for this piece
C. Neill Epperson, MD
Robert Freedman Endowed Professor and Chair of the Department of Psychiatry, University of Colorado Anschutz Medical Campus. Her research career has focused on how reproductive hormone transitions, including the menopause transition, act on mood, anxiety and cognition.
What we read: her published work on hormone-driven mood disorders, and the allopregnanolone/GABA mechanism research it draws on, which underlies the mechanism this piece describes.²
Where to follow her work: Faculty profile
Who else has measured this
The mechanism above has been measured and reviewed from more than one direction.
Peter J. Schmidt, MD, Chief of the Section on Behavioral Endocrinology at the National Institute of Mental Health, co-authored the review establishing allopregnanolone’s role as a mediator of mood switching in reproductive hormone disorders — the mechanism section above draws directly on that work.² NIMH profile
Pauline M. Maki, PhD, Professor of Psychiatry and Psychology at the University of Illinois Chicago, led the panel that produced NAMS’s clinical guidelines for evaluating and treating perimenopausal mood symptoms, the source for the prevalence figures cited above.³ Faculty profile
Mary Claire Haver, MD, a board-certified OB/GYN and author of The New Menopause, popularized the “zone of chaos” description of erratic hormone swings from her own clinical practice. Her framing is drawn from patient-facing experience rather than a controlled study, and is cited here for that clinical observation specifically, not as a substitute for the peer-reviewed mechanism research above.¹ Wikipedia · Instagram · LinkedIn
The 3-day pattern check (a few minutes each evening)
For three evenings in a row, write four short lines. What time the anxiety spiked hardest. What you’d eaten and slept the night before. Where you were in your cycle, if you’re still tracking one, or roughly how the week has felt hormonally if you’re not. And one word for what it felt like in your body, tight chest, racing thoughts, restlessness.
After three days, read it back looking for one thing only: does it cluster. Most women find it does, worse on less sleep, worse at a specific point in the cycle, worse after a skipped meal. That cluster is useful information for a doctor’s appointment and, on its own, a real relief: a pattern has a shape. A shapeless feeling that could strike at any red light does not.
Three days is deliberately short. This isn’t a wellness habit meant to run forever, it’s a diagnostic snapshot, closer to a food diary before an allergy test than a journaling practice. Once the shape is visible, most women stop logging and just watch for the known pattern instead, which takes far less effort than tracking everything indefinitely.
Common questions about menopause anxiety
Can menopause really cause anxiety in someone who’s never had it before?
Yes. New-onset anxiety during perimenopause is well documented and common, tied to the same estrogen and progesterone shifts covered above, not a sign of a pre-existing condition finally surfacing.¹³
Does HRT help with menopause-related anxiety?
For some women, stabilizing the hormone swings measurably eases the anxiety that tracks with them, though it isn’t a universal fix and the decision depends on individual health history. That conversation belongs with a clinician familiar with your full picture, not a general rule. Informational, not medical advice.
Why does the anxiety often feel worse at night or in the car, specifically?
Both are low-stimulation moments where there’s nothing external to explain the physical sensation, which makes an internally generated hormonal spike stand out more sharply than it would during a busy, distracting stretch of the day.
Is tracking my symptoms for three days really going to tell me anything useful?
It’s a short enough window to actually complete and a long enough one to catch an obvious pattern like sleep, cycle timing, or meals. Most women extend it once they see how much clearer even three days makes things.
What if the pattern check shows no clear cluster at all?
That’s useful information too. A genuinely random pattern, rather than one tied to sleep or cycle timing, is worth mentioning specifically to a clinician, since it may point toward a different or additional factor worth ruling out.
Could this actually be perimenopause if my periods haven’t changed yet?
Yes. Cycle changes are one of the later, more visible signs for a lot of women, not the earliest one. Hormone fluctuation, and the mood effects it carries, can start years before periods become noticeably irregular, which is exactly why anxiety alone often doesn’t get connected to this cause until much later than it could have been.
Does exercise or diet actually change this hormonal pattern?
They can soften the edges, better sleep and steadier blood sugar both support a calmer nervous system generally, but they don’t reverse the underlying hormone shift itself. Worth doing for how they help day to day. Not a substitute for naming the actual mechanism at work.
If this anxiety is one thread in a bigger pattern, always managing everyone else’s needs while quietly unraveling on the inside, that’s worth a longer look than a 3-day log.
The one move
This anxiety is rarely just about hormones alone — it often arrives on top of a load you were already carrying without naming it. The Quiet Audit is ten quiet minutes of questions, not a diagnosis.
The red light will change. What you do with the next one is worth ten minutes. Start here.
On the researcher. C. Neill Epperson is a psychiatrist and researcher, not a source of individual diagnosis: her work describes population-level mechanisms linking hormone transitions to mood, and is not a substitute for an evaluation from a clinician who knows your history.
Sourcing, disclosure and disclaimers
This is not medical advice. Blue Leaf Journal publishes general information for a general readership. Nothing here is a diagnosis, a treatment recommendation, or a substitute for care from a clinician who knows your history.
We are not clinicians. Blue Leaf Journal is an independent publication. We read published research and translate it. The findings belong to the researchers and institutions named and linked above; the plain-English rendering is ours, and so is any error in it.
No affiliation and no endorsement. Blue Leaf Journal is not affiliated with C. Neill Epperson, Peter J. Schmidt, Pauline M. Maki, Mary Claire Haver, the University of Colorado Anschutz Medical Campus, the National Institute of Mental Health, the University of Illinois Chicago, or The Menopause Society (NAMS). None of them has reviewed, approved or endorsed this article, and none of them is responsible for it. They are cited because their published work, or in Dr. Haver’s case her widely used clinical framing, is the basis for what it says.
No commercial relationship. Nobody named above paid for or was paid for this coverage. There are no affiliate links, no sponsored placements and no gifted products in this article.
How this was checked. Every figure above is drawn from the primary papers, each linked in the references, and can be verified there. Sources were checked on 7 September 2026. If you find something we have got wrong, write to norawhitfield@blueleafjournal.com and we will correct it and say that we did.
References
1. Haver, M.C., clinical framing on perimenopause hormone chaos, mood, and anxiety. The New Menopause (2024); thepauselife.com.
2. Schiller, C.E., Schmidt, P.J., & Rubinow, D.R. (2014). Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology, 231(17), 3557–3567. link.springer.com/article/10.1007/s00213-014-3599-x
3. Maki, P.M. et al. (2018). Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of Women’s Health, 27(2), 117–126, on behalf of The North American Menopause Society (NAMS). doi.org/10.1089/jwh.2018.27099.mensocrec
Nora Whitfield writes for Blue Leaf Journal, where the working rule is that a mechanism you can name is easier to live with than one you cannot. She reads the limitations section before the conclusion, and passes on what she finds there.
Written by Nora Whitfield for Blue Leaf Journal. Updated: 7 September 2026.
